Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheters

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-17
SponsorDokuz Eylul University

About this trial

In order to provide treatment in pediatric hematology-oncology patients, in some cases a central venous catheter is required in children. The most important situation to pay attention to when using a central venous catheter is "Central line-associated bloodstream infections".

These infections are infections that develop after admission to the hospital and are not in the incubation period at the time of admission, or although they usually develop in the hospital 48-72 hours after hospitalization, they can sometimes appear after discharge. Central line-associated bloodstream infections significantly increase morbidity and mortality. In this context, the effect of using a care bundle containing chlorhexidine dressing on port catheter and central venous catheter-related bloodstream infections in pediatric cancer patients was examined.

Eligibility criteria

Qualifiers

The child is receiving inpatient treatment at the Hematology and Oncology unit and hematopoietic stem cell transplantation unit

The child has a diagnosis of hematological or oncological cancer

The child's age range is between 1 and 17

Having a port catheter inserted and no early complications have occurred

Disqualifiers

Have a systemic infection.

Trial design

Treatments tested in this trial

  • Chlorhexidine Dressing

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Dokuz Eylul University

Lead sponsor

Afyonkarahisar Health Science University

Collaborator